{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:27:07Z","timestamp":1793114827787,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010613","name":"Taipei Medical University Hospital","doi-asserted-by":"crossref","award":["103TMUH-WFH-02-3"],"award-info":[{"award-number":["103TMUH-WFH-02-3"]}],"id":[{"id":"10.13039\/501100010613","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST104-2314-B-038-062"],"award-info":[{"award-number":["MOST104-2314-B-038-062"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health and Welfare Surcharge of Tobacco Products grant","award":["MOHW110-TDU-B-212-144014"],"award-info":[{"award-number":["MOHW110-TDU-B-212-144014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10456-024-09944-6","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T07:05:52Z","timestamp":1724396752000},"page":"827-843","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The angiogenic role of the alpha 9-nicotinic acetylcholine receptor in triple-negative breast cancers"],"prefix":"10.1007","volume":"27","author":[{"given":"Sonjid","family":"Ochirbat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Chun","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Hsuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Hsiang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chia","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri","family":"Rahayu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungshan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"issue":"9","key":"9944_CR1","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","volume":"77","author":"R Lugano","year":"2020","unstructured":"Lugano R, Ramachandran M, Dimberg A (2020) Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci 77(9):1745\u20131770","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"9944_CR2","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s11033-020-05306-9","volume":"47","author":"MF Behelgardi","year":"2020","unstructured":"Behelgardi MF et al (2020) Targeting signaling pathways of VEGFR1 and VEGFR2 as a potential target in the treatment of breast cancer. Mol Biol Rep 47(3):2061\u20132071","journal-title":"Mol Biol Rep"},{"issue":"3","key":"9944_CR3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/CS20040370","volume":"109","author":"H Takahashi","year":"2005","unstructured":"Takahashi H, Shibuya M (2005) The vascular endothelial growth factor (VEGF)\/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond) 109(3):227\u2013241","journal-title":"Clin Sci (Lond)"},{"issue":"7","key":"9944_CR4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc2868","volume":"10","author":"AS Chung","year":"2010","unstructured":"Chung AS, Lee J, Ferrara N (2010) Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer 10(7):505\u2013514","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"9944_CR5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10549-017-4189-5","volume":"163","author":"S Zhang","year":"2017","unstructured":"Zhang S et al (2017) Immunoglobulin-like domain 4-mediated ligand-independent dimerization triggers VEGFR-2 activation in HUVECs and VEGFR2-positive breast cancer cells. Breast Cancer Res Treat 163(3):423\u2013434","journal-title":"Breast Cancer Res Treat"},{"key":"9944_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08796-z","author":"GG Jinesh","year":"2017","unstructured":"Jinesh GG et al (2017) Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesis. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-017-08796-z","journal-title":"Sci Rep"},{"issue":"1","key":"9944_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2016.01.010","volume":"373","author":"M Luo","year":"2016","unstructured":"Luo M et al (2016) VEGF\/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-kappaB and beta-catenin. Cancer Lett 373(1):1\u201311","journal-title":"Cancer Lett"},{"issue":"24","key":"9944_CR8","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1038\/onc.2014.257","volume":"34","author":"D Zhao","year":"2015","unstructured":"Zhao D et al (2015) VEGF drives cancer-initiating stem cells through VEGFR-2\/Stat3 signaling to upregulate Myc and Sox2. Oncogene 34(24):3107\u20133119","journal-title":"Oncogene"},{"key":"9944_CR9","first-page":"159","volume":"6","author":"X Zhu","year":"2015","unstructured":"Zhu X, Zhou W (2015) The emerging regulation of VEGFR-2 in triple-negative breast cancer. Front Endocrinol (Lausanne) 6:159","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"14","key":"9944_CR10","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1158\/1078-0432.CCR-13-1916","volume":"20","author":"E Riquelme","year":"2014","unstructured":"Riquelme E et al (2014) VEGF\/VEGFR-2 upregulates EZH2 expression in lung adenocarcinoma cells and EZH2 depletion enhances the response to platinum-based and VEGFR-2-targeted therapy. Clin Cancer Res 20(14):3849\u20133861","journal-title":"Clin Cancer Res"},{"issue":"10","key":"9944_CR11","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1200\/JCO.2014.55.9575","volume":"33","author":"C Lu-Emerson","year":"2015","unstructured":"Lu-Emerson C et al (2015) Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma. J Clin Oncol 33(10):1197\u20131213","journal-title":"J Clin Oncol"},{"issue":"6","key":"9944_CR12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179202","volume":"12","author":"N Mahfouz","year":"2017","unstructured":"Mahfouz N et al (2017) Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1alpha and VEGF receptors. PLoS ONE 12(6):e0179202","journal-title":"PLoS ONE"},{"key":"9944_CR13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.canlet.2017.06.027","volume":"403","author":"ZY Zhong","year":"2017","unstructured":"Zhong ZY et al (2017) Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA\/VEGFR2 signaling pathway. Cancer Lett 403:305\u2013317","journal-title":"Cancer Lett"},{"key":"9944_CR14","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20170270","author":"S Pengcheng","year":"2017","unstructured":"Pengcheng S et al (2017) MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20170270"},{"issue":"3","key":"9944_CR15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.15252\/emmm.201606840","volume":"9","author":"K Jang","year":"2017","unstructured":"Jang K et al (2017) VEGFA activates an epigenetic pathway upregulating ovarian cancer-initiating cells. EMBO Mol Med 9(3):304\u2013318","journal-title":"EMBO Mol Med"},{"key":"9944_CR16","doi-asserted-by":"crossref","first-page":"e3015","DOI":"10.1038\/cddis.2017.422","volume":"8","author":"KS Liu","year":"2017","unstructured":"Liu KS et al (2017) Apatinib promotes autophagy and apoptosis through VEGFR2\/STAT3\/BCL-2 signaling in osteosarcoma. Cell Death Dis 8:e3015","journal-title":"Cell Death Dis"},{"issue":"6","key":"9944_CR17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4161\/cam.23332","volume":"6","author":"M Perrot-Applanat","year":"2012","unstructured":"Perrot-Applanat M, Di Benedetto M (2012) Autocrine functions of VEGF in breast tumor cells: adhesion, survival, migration and invasion. Cell Adh Migr 6(6):547\u2013553","journal-title":"Cell Adh Migr"},{"issue":"7","key":"9944_CR18","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/89961","volume":"7","author":"C Heeschen","year":"2001","unstructured":"Heeschen C et al (2001) Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 7(7):833\u2013839","journal-title":"Nat Med"},{"issue":"4","key":"9944_CR19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI0214676","volume":"110","author":"C Heeschen","year":"2002","unstructured":"Heeschen C et al (2002) A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest 110(4):527\u2013536","journal-title":"J Clin Invest"},{"issue":"1","key":"9944_CR20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","volume":"89","author":"EX Albuquerque","year":"2009","unstructured":"Albuquerque EX et al (2009) Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89(1):73\u2013120","journal-title":"Physiol Rev"},{"key":"9944_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-13665-3_1","volume":"23","author":"F Fasoli","year":"2015","unstructured":"Fasoli F, Gotti C (2015) Structure of neuronal nicotinic receptors. Curr Top Behav Neurosci 23:1\u201317","journal-title":"Curr Top Behav Neurosci"},{"issue":"4","key":"9944_CR22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/neu.10153","volume":"53","author":"N Le Novere","year":"2002","unstructured":"Le Novere N, Corringer PJ, Changeux JP (2002) The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J Neurobiol 53(4):447\u2013456","journal-title":"J Neurobiol"},{"issue":"6","key":"9944_CR23","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1523\/JNEUROSCI.5438-11.2012","volume":"32","author":"AP Govind","year":"2012","unstructured":"Govind AP, Walsh H, Green WN (2012) Nicotine-induced upregulation of native neuronal nicotinic receptors is caused by multiple mechanisms. J Neurosci 32(6):2227\u20132238","journal-title":"J Neurosci"},{"issue":"46","key":"9944_CR24","doi-asserted-by":"crossref","first-page":"33049","DOI":"10.1074\/jbc.M113.501601","volume":"288","author":"KC Brown","year":"2013","unstructured":"Brown KC et al (2013) Nicotine induces the up-regulation of the alpha7-nicotinic receptor (alpha7-nAChR) in human squamous cell lung cancer cells via the Sp1\/GATA protein pathway. J Biol Chem 288(46):33049\u201333059","journal-title":"J Biol Chem"},{"issue":"8","key":"9944_CR25","volume":"7","author":"D Shi","year":"2012","unstructured":"Shi D et al (2012) Nicotine promotes proliferation of human nasopharyngeal carcinoma cells by regulating alpha7AChR, ERK, HIF-1alpha and VEGF\/PEDF signaling. PLoS ONE 7(8):e43898","journal-title":"PLoS ONE"},{"issue":"2","key":"9944_CR26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.taap.2014.04.023","volume":"278","author":"X Ma","year":"2014","unstructured":"Ma X et al (2014) alpha5 Nicotinic acetylcholine receptor mediates nicotine-induced HIF-1alpha and VEGF expression in non-small cell lung cancer. Toxicol Appl Pharmacol 278(2):172\u2013179","journal-title":"Toxicol Appl Pharmacol"},{"issue":"17","key":"9944_CR27","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/jnci\/djq300","volume":"102","author":"CH Lee","year":"2010","unstructured":"Lee CH et al (2010) Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells. J Natl Cancer Inst 102(17):1322\u20131335","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"9944_CR28","first-page":"1","volume":"18","author":"Z Sun","year":"2020","unstructured":"Sun Z et al (2020) Differential expression of nicotine acetylcholine receptors associates with human breast cancer and mediates antitumor activity of alphaO-conotoxin GeXIVA. Mar Drugs 18(1):1\u201361","journal-title":"Mar Drugs"},{"key":"9944_CR29","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/456743","volume":"2011","author":"S Singh","year":"2011","unstructured":"Singh S, Pillai S, Chellappan S (2011) Nicotinic acetylcholine receptor signaling in tumor growth and metastasis. J Oncol 2011:456743","journal-title":"J Oncol"},{"key":"9944_CR30","volume":"15","author":"S Pucci","year":"2021","unstructured":"Pucci S et al (2021) alpha9-containing nicotinic receptors in cancer. Front Cell Neurosci 15:805123","journal-title":"Front Cell Neurosci"},{"key":"9944_CR31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fncel.2017.00336","volume":"11","author":"LC Huang","year":"2017","unstructured":"Huang LC et al (2017) Nicotinic acetylcholine receptor subtype alpha-9 mediates triple-negative breast cancers based on a spontaneous pulmonary metastasis mouse model. Front Cell Neurosci 11:336","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"9944_CR32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10549-014-2912-z","volume":"145","author":"P Guha","year":"2014","unstructured":"Guha P et al (2014) Nicotine promotes apoptosis resistance of breast cancer cells and enrichment of side population cells with cancer stem cell-like properties via a signaling cascade involving galectin-3, alpha9 nicotinic acetylcholine receptor and STAT3. Breast Cancer Res Treat 145(1):5\u201322","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"9944_CR33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1039\/D1BM01218E","volume":"10","author":"M Chen","year":"2021","unstructured":"Chen M et al (2021) A novel anti-tumor\/anti-tumor-associated fibroblast\/anti-mPEG tri-specific antibody to maximize the efficacy of mPEGylated nanomedicines against fibroblast-rich solid tumor. Biomater Sci 10(1):202\u2013215","journal-title":"Biomater Sci"},{"issue":"6","key":"9944_CR34","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/healthcare9060647","volume":"9","author":"C Pintavirooj","year":"2021","unstructured":"Pintavirooj C et al (2021) Noninvasive portable hemoglobin concentration monitoring system using optical sensor for anemia disease. Healthcare (Basel) 9(6):647","journal-title":"Healthcare (Basel)"},{"key":"9944_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.805123","author":"S Pucci","year":"2022","unstructured":"Pucci S et al (2022) \u03b19-containing nicotinic receptors in cancer. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2021.805123","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"9944_CR36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10549-014-2912-z","volume":"145","author":"P Guha","year":"2014","unstructured":"Guha P et al (2014) Nicotine promotes apoptosis resistance of breast cancer cells and enrichment of side population cells with cancer stem cell-like properties via a signaling cascade involving galectin-3, \u03b19 nicotinic acetylcholine receptor and STAT3. Breast Cancer Res Treat 145(1):5\u201322","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"9944_CR37","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1167\/iovs.16-20670","volume":"58","author":"SF Hackett","year":"2017","unstructured":"Hackett SF et al (2017) The nicotinic cholinergic pathway contributes to retinal neovascularization in a mouse model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 58(2):1296\u20131303","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"9944_CR38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jcb.22270","volume":"108","author":"JC Wu","year":"2009","unstructured":"Wu JC et al (2009) Cholinergic modulation of angiogenesis: role of the 7 nicotinic acetylcholine receptor. J Cell Biochem 108(2):433\u2013446","journal-title":"J Cell Biochem"},{"issue":"12","key":"9944_CR39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3858\/emm.2009.41.12.103","volume":"41","author":"L Chen","year":"2009","unstructured":"Chen L, Endler A, Shibasaki F (2009) Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors. Exp Mol Med 41(12):849\u2013857","journal-title":"Exp Mol Med"},{"issue":"1","key":"9944_CR40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12307-008-0013-4","volume":"1","author":"AP Elias","year":"2008","unstructured":"Elias AP, Dias S (2008) Microenvironment changes (in pH) affect VEGF alternative splicing. Cancer Microenviron 1(1):131\u2013139","journal-title":"Cancer Microenviron"},{"key":"9944_CR41","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399409001173","volume":"11","author":"E Poon","year":"2009","unstructured":"Poon E, Harris AL, Ashcroft M (2009) Targeting the hypoxia-inducible factor (HIF) pathway in cancer. Expert Rev Mol Med 11:e26","journal-title":"Expert Rev Mol Med"},{"key":"9944_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16405-x","author":"OY Hong","year":"2022","unstructured":"Hong OY et al (2022) Inhibition of cell invasion and migration by targeting matrix metalloproteinase-9 expression via sirtuin 6 silencing in human breast cancer cells. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-16405-x","journal-title":"Sci Rep"},{"issue":"7","key":"9944_CR43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tcm.2008.11.007","volume":"18","author":"JP Cooke","year":"2008","unstructured":"Cooke JP, Ghebremariam YT (2008) Endothelial nicotinic acetylcholine receptors and angiogenesis. Trends Cardiovasc Med 18(7):247\u2013253","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"9944_CR44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10549-010-1209-0","volume":"129","author":"CH Lee","year":"2011","unstructured":"Lee CH et al (2011) Crosstalk between nicotine and estrogen-induced estrogen receptor activation induces \u03b19-nicotinic acetylcholine receptor expression in human breast cancer cells. Breast Cancer Res Treat 129(2):331\u2013345","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"9944_CR45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/mnfr.201000254","volume":"55","author":"SH Tu","year":"2011","unstructured":"Tu SH et al (2011) Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced alpha9-nicotinic acetylcholine receptor upregulation in human breast cancer cells. Mol Nutr Food Res 55(3):455\u2013466","journal-title":"Mol Nutr Food Res"},{"issue":"3","key":"9944_CR46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10456-009-9146-4","volume":"12","author":"I Arnaoutova","year":"2009","unstructured":"Arnaoutova I et al (2009) The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis 12(3):267\u2013274","journal-title":"Angiogenesis"},{"issue":"4","key":"9944_CR47","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1083\/jcb.107.4.1589","volume":"107","author":"Y Kubota","year":"1988","unstructured":"Kubota Y et al (1988) Role of laminin and basement-membrane in the morphological-differentiation of human-endothelial cells into capillary-like structures. J Cell Biol 107(4):1589\u20131598","journal-title":"J Cell Biol"},{"issue":"2","key":"9944_CR48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/sj.bjp.0705051","volume":"138","author":"MG Cattaneo","year":"2003","unstructured":"Cattaneo MG et al (2003) Alprostadil suppresses angiogenesis in vitro and in vivo in the murine Matrigel plug assay. Br J Pharmacol 138(2):377\u2013385","journal-title":"Br J Pharmacol"},{"issue":"2","key":"9944_CR49","first-page":"305","volume":"22","author":"M Kragh","year":"2003","unstructured":"Kragh M et al (2003) In vivo chamber angiogenesis assay: an optimized Matrigel plug assay for fast assessment of anti-angiogenic activity. Int J Oncol 22(2):305\u2013311","journal-title":"Int J Oncol"},{"issue":"16","key":"9944_CR50","doi-asserted-by":"crossref","first-page":"8909","DOI":"10.3390\/ijms22168909","volume":"22","author":"Z Aref","year":"2021","unstructured":"Aref Z, Quax PHA (2021) In vivo Matrigel plug assay as a potent method to investigate specific individual contribution of angiogenesis to blood flow recovery in mice. Int J Mol Sci 22(16):8909","journal-title":"Int J Mol Sci"},{"issue":"4","key":"9944_CR51","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3390\/biom12040480","volume":"12","author":"WT Huang","year":"2022","unstructured":"Huang WT et al (2022) Microtube array membrane hollow fiber assay (MTAM-HFA)-an accurate and rapid potential companion diagnostic and pharmacological interrogation solution for cancer immunotherapy (PD-1\/PD-L1). Biomolecules 12(4):480","journal-title":"Biomolecules"},{"issue":"12","key":"9944_CR52","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1947601911423031","volume":"2","author":"M Shibuya","year":"2011","unstructured":"Shibuya M (2011) Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer 2(12):1097\u20131105","journal-title":"Genes Cancer"},{"issue":"4","key":"9944_CR53","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12079-016-0352-8","volume":"10","author":"CS Abhinand","year":"2016","unstructured":"Abhinand CS et al (2016) VEGF-A\/VEGFR2 signaling network in endothelial cells relevant to angiogenesis. J Cell Commun Signal 10(4):347\u2013354","journal-title":"J Cell Commun Signal"},{"key":"9944_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/srep45954","author":"M Momeny","year":"2017","unstructured":"Momeny M et al (2017) Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells. Sci Rep. https:\/\/doi.org\/10.1038\/srep45954","journal-title":"Sci Rep"},{"issue":"12","key":"9944_CR55","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1177\/1947601911423654","volume":"2","author":"BL Krock","year":"2011","unstructured":"Krock BL, Skuli N, Simon MC (2011) Hypoxia-induced angiogenesis: good and evil. Genes Cancer 2(12):1117\u20131133","journal-title":"Genes Cancer"},{"issue":"4","key":"9944_CR56","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/cdd.2008.21","volume":"15","author":"EB Rankin","year":"2008","unstructured":"Rankin EB, Giaccia AJ (2008) The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15(4):678\u2013685","journal-title":"Cell Death Differ"},{"issue":"22","key":"9944_CR57","doi-asserted-by":"crossref","first-page":"9212","DOI":"10.1158\/0008-5472.CAN-08-1135","volume":"68","author":"K Helczynska","year":"2008","unstructured":"Helczynska K et al (2008) Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer. Cancer Res 68(22):9212\u20139220","journal-title":"Cancer Res"},{"issue":"1","key":"9944_CR58","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/01.pai.0000145182.98577.10","volume":"14","author":"A Giatromanolaki","year":"2006","unstructured":"Giatromanolaki A et al (2006) Hypoxia-inducible factor-2 alpha (HIF-2 alpha) induces angiogenesis in breast carcinomas. Appl Immunohistochem Mol Morphol 14(1):78\u201382","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"10","key":"9944_CR59","doi-asserted-by":"crossref","first-page":"C1531","DOI":"10.1152\/ajpcell.00052.2012","volume":"302","author":"S Salman","year":"2012","unstructured":"Salman S, Brown ST, Nurse CA (2012) Chronic nicotine induces hypoxia inducible factor-2alpha in perinatal rat adrenal chromaffin cells: role in transcriptional upregulation of KATP channel subunit Kir6.2. Am J Physiol Cell Physiol 302(10):C1531-8","journal-title":"Am J Physiol Cell Physiol"},{"key":"9944_CR60","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3389\/fonc.2019.01370","volume":"9","author":"S Quintero-Fabian","year":"2019","unstructured":"Quintero-Fabian S et al (2019) Role of matrix metalloproteinases in angiogenesis and cancer. Front Oncol 9:1370","journal-title":"Front Oncol"},{"issue":"4","key":"9944_CR61","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/bcr65","volume":"2","author":"MJ Duffy","year":"2000","unstructured":"Duffy MJ et al (2000) Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2(4):252\u2013257","journal-title":"Breast Cancer Res"},{"issue":"1","key":"9944_CR62","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1006458601568","volume":"65","author":"A Talvensaari-Mattila","year":"2001","unstructured":"Talvensaari-Mattila A et al (2001) Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy. Breast Cancer Res Treat 65(1):55\u201361","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"9944_CR63","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/A:1006326513176","volume":"58","author":"A Talvensaari-Mattila","year":"1999","unstructured":"Talvensaari-Mattila A, Paakko P, Turpeenniemi-Hujanen T (1999) MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma. Breast Cancer Res Treat 58(3):287\u2013293","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"9944_CR64","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1153::AID-CNCR14>3.0.CO;2-4","volume":"83","author":"A Talvensaari-Mattila","year":"1998","unstructured":"Talvensaari-Mattila A et al (1998) Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma. Cancer 83(6):1153\u20131162","journal-title":"Cancer"},{"issue":"1","key":"9944_CR65","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1021152910976","volume":"77","author":"R Hirvonen","year":"2003","unstructured":"Hirvonen R et al (2003) Matrix metalloproteinase-2 (MMP-2) in T(1\u20132)N0 breast carcinoma. Breast Cancer Res Treat 77(1):85\u201391","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"9944_CR66","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0092-8674(00)00139-2","volume":"103","author":"LM Coussens","year":"2000","unstructured":"Coussens LM et al (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103(3):481\u2013490","journal-title":"Cell"},{"issue":"10","key":"9944_CR67","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","volume":"2","author":"G Bergers","year":"2000","unstructured":"Bergers G et al (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2(10):737\u2013744","journal-title":"Nat Cell Biol"},{"issue":"2","key":"9944_CR68","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0002-9440(10)64859-6","volume":"160","author":"BS Conklin","year":"2002","unstructured":"Conklin BS et al (2002) Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. Am J Pathol 160(2):413\u2013418","journal-title":"Am J Pathol"},{"issue":"7","key":"9944_CR69","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1074\/jbc.M210063200","volume":"278","author":"TH Lee","year":"2003","unstructured":"Lee TH et al (2003) Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability. J Biol Chem 278(7):5277\u20135284","journal-title":"J Biol Chem"},{"issue":"2","key":"9944_CR70","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1016-8478(23)13780-0","volume":"16","author":"T Natori","year":"2003","unstructured":"Natori T et al (2003) Nicotine enhances neovascularization and promotes tumor growth. Mol Cells 16(2):143\u2013146","journal-title":"Mol Cells"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-024-09944-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10456-024-09944-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-024-09944-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T08:24:38Z","timestamp":1731572678000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10456-024-09944-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["9944"],"URL":"https:\/\/doi.org\/10.1007\/s10456-024-09944-6","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]},"assertion":[{"value":"5 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}